Form CORRESP - Correspondence:
SEC Accession No. 0001193125-18-166350
Filing Date
2018-05-17
Accepted
2018-05-17 13:50:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10175
2 GRAPHIC g569279ig1.jpg GRAPHIC 19034
3 GRAPHIC g569279ig2.jpg GRAPHIC 1682
  Complete submission text file 0001193125-18-166350.txt   40191
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations